These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 20880544)
1. Expression of multidrug resistance-associated P-glycoprotein in feline tumours. Van der Heyden S; Chiers K; Vercauteren G; Daminet S; Wegge B; Paepe D; Ducatelle R J Comp Pathol; 2011; 144(2-3):164-9. PubMed ID: 20880544 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of P-glycoprotein (clone C494) in canine mammary gland tumours. Petterino C; Rossetti E; Bertoncello D; Martini M; Zappulli V; Bargelloni L; Castagnaro M J Vet Med A Physiol Pathol Clin Med; 2006 May; 53(4):174-8. PubMed ID: 16629950 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of STAT3-p-tyr705 expression in feline mammary gland tumours and correlation with histologic grade. Petterino C; Ratto A; Podestà G; Drigo M; Pellegrino C Res Vet Sci; 2007 Apr; 82(2):218-24. PubMed ID: 16934302 [TBL] [Abstract][Full Text] [Related]
4. P-glycoprotein expression in non-Hodgkin's lymphomas of human immunodeficiency virus infected patients. Tanaka PY; Calore EE Pathol Res Pract; 2007; 203(1):1-7. PubMed ID: 17157997 [TBL] [Abstract][Full Text] [Related]
5. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of P-glycoprotein expression in feline lymphoma and correlation with clinical outcome. Brenn SH; Couto SS; Craft DM; Leung C; Bergman PJ Vet Comp Oncol; 2008 Sep; 6(3):201-11. PubMed ID: 19178680 [TBL] [Abstract][Full Text] [Related]
7. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein expression in the squamous cell carcinoma of the tongue base. Rabkin D; Chhieng DC; Miller MB; Jennings T; Feustel P; Steiniger J; Parnes SM Laryngoscope; 1995 Dec; 105(12 Pt 1):1294-9. PubMed ID: 8523980 [TBL] [Abstract][Full Text] [Related]
9. Metallothionein expression in canine and feline mammary and melanotic tumours. Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128 [TBL] [Abstract][Full Text] [Related]
10. The human multidrug resistance gene (MDR-1): immunocytochemical detection of its expression in oral SCC. Lo Muzio L; Staibano S; Pannone G; Mignogna MD; Serpico R; Rubini C; Fioroni M; Fanali S; Piattelli A Anticancer Res; 2000; 20(5A):2891-7. PubMed ID: 11062698 [TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential. Alemán C; Annereau JP; Liang XJ; Cardarelli CO; Taylor B; Yin JJ; Aszalos A; Gottesman MM Cancer Res; 2003 Jun; 63(12):3084-91. PubMed ID: 12810633 [TBL] [Abstract][Full Text] [Related]
12. Tissue distribution of p-glycoprotein in cats. Van Der Heyden S; Chiers K; Ducatelle R Anat Histol Embryol; 2009 Nov; 38(6):455-60. PubMed ID: 19860748 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia. Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123 [TBL] [Abstract][Full Text] [Related]
14. Generation of multidrug resistant lymphoma cell lines stably expressing P-glycoprotein. Pop I; Pop L; Vitetta ES; Ghetie MA Oncol Rep; 2008 Apr; 19(4):889-95. PubMed ID: 18357372 [TBL] [Abstract][Full Text] [Related]
15. Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference. Stege A; Priebsch A; Nieth C; Lage H Cancer Gene Ther; 2004 Nov; 11(11):699-706. PubMed ID: 15375376 [TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5. Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135 [TBL] [Abstract][Full Text] [Related]
17. Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cells. Ghetie MA; Ghetie V; Vitetta ES Clin Cancer Res; 1999 Dec; 5(12):3920-7. PubMed ID: 10632321 [TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance and malignancy in human osteosarcoma. Scotlandi K; Serra M; Nicoletti G; Vaccari M; Manara MC; Nini G; Landuzzi L; Colacci A; Bacci G; Bertoni F; Picci P; Campanacci M; Baldini N Cancer Res; 1996 May; 56(10):2434-9. PubMed ID: 8625324 [TBL] [Abstract][Full Text] [Related]
20. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors. Ressel L; Millanta F; Caleri E; Innocenti VM; Poli A Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]